文献速递母胎医学

性染色体异常无创产前DNA筛查的确诊率因确诊检测方法而异

Confirmation rate of cell free DNA screening for sex chromosomal abnormalities according to the method of confirmatory testing.
PubMed 文献 · Prenat Diagn · 2020-09-02

基于超过90000例样本的回顾性研究,分析144例性染色体非整倍体(SCA)高风险病例,总体阳性预测值(PPV)为38.9%,单体X的PPV为29.0%。确诊检测方法影响PPV:羊膜腔穿刺29.5% vs 绒毛膜取样50.0%,差异由单体X驱动(绒毛膜取样54.6% vs 羊膜腔穿刺17.1%)。

要点

  • 确诊方法影响PPV:绒毛膜取样50.0% vs 羊膜腔穿刺29.5%,差异由单体X驱动。
  • 单体X的PPV在绒毛膜取样为54.6%,在羊膜腔穿刺为17.1%。

核心结论

  • 异常cfDNA筛查SCA的PPV低,尤其是单体X,确诊率取决于确诊检测类型。

研究设计与样本

  • 基于送至Cenata私营实验室并使用Harmony产前检测的样本的回顾性研究,研究人群包括144例SCA高风险病例。

主要发现

  • cfDNA提示单体X、XXX、XXY和XYY的病例数分别为62例、37例、40例和5例。
  • 112例(77.8%)SCA高风险女性选择产前核型分析。
  • 在该组中,羊膜腔穿刺与绒毛膜取样评估核型时的PPV存在显著差异:29.5% vs 50.0%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the positive predictive value (PPV) of cfDNA screening for sex chromosome aneuploidies (SCA) in a large series of over 90 000 patients. METHODS: Retrospective study based on samples that were sent to Cenata, a private laboratory which uses the Harmony Prenatal Test. The SCA high-risk results were stratified according to the method of diagnostic testing and according to karyotype result. RESULTS: The study population consisted of 144 cases. The CfDNA test indicated monosomy X, XXX, XXY, and XYY in 62, 37, 40, and 5 cases, respectively. The overall PPV was 38.9% (30.9-47.4), 29.0% (18.2-42.9) for monosomy X, 29.7% (15.9-47.9) for 47,XXX, 57.5% (40.9-73.0) for 47,XXY, and 80.0% (28.4-99.5) for 47,XYY). A total of 112 (77.8%) women with a high-risk result for SCAs opted for prenatal karyotyping. In this group, there were significant differences in the PPV if the karyotype was assessed by amniocentesis or by CVS: 29.5% vs 50.0%. This significant difference was driven by the monosomy X result which shows a significantly higher PPV in CVS (54.6% (23.4-83.3) vs 17.1% (6.6-33.6)). For the other SCAs, the differences were not significant. CONCLUSION: PPV of an abnormal cfDNA test for SCAs is low, particularly for monosomy X. The confirmation rate depends on the type of confirmatory test.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Lüthgens K, Grati FR, Sinzel M, et al. Confirmation rate of cell free DNA screening for sex chromosomal abnormalities according to the method of confirmatory testing. Prenat Diagn. 2020. PMID: 32804406. doi:10.1002/pd.5814

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。